FDA Approved: RYDAPT — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved RYDAPT (midostaurin) under its original application for an indication in adults with acute myeloid leukemia with FLT3 mutation, based on pivotal tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Systemic Mastocytosis

Drugs mentioned

• Rydapt (midostaurin)

Snippet

ORIG AP for RYDAPT (RYDAPT)